Although previous studies showed that patients with AR+ breast tumors showed prolonged survival and better response to hormone treatments, as androgens levels are positively associated with breast cancer risk in post-menopausal women, suggesting that It may be the AR expression that correlates with ER expression, but more studies are needed to prove this. This evidence concerns the gene AR and breast cancer.